Scientists have identified a biological tipping point in microglial behavior that may determine whether Alzheimer's pathology leads to dementia, offering new treatment targets.
A new study reveals that cancer-linked mutations found in immune cells may contribute to Alzheimer's disease, suggesting new diagnostic and treatment avenues.
Scientists at ETH Zurich identified a new Alzheimer's trigger and developed an experimental compound that slowed nerve cell loss and extended lifespan in mice.
Scientists have identified acetylcholine as a key brain chemical that helps individuals break bad habits and adapt to new situations, with implications for treating addiction and neurological disorders.
A study found that epigenetic changes at birth influence gut bacteria development, which is linked to early signs of autism and ADHD, with certain microbes potentially offering protection.
Scientists have discovered a molecular switch involving the STING protein that drives brain inflammation in Alzheimer's disease, offering a new target for treatments.
Researchers developed a nasal spray that reversed brain aging and improved memory in test models by reducing inflammation and restoring cellular energy.
A brain protein called Menin may drive aging and cognitive decline, and its restoration or a D-serine supplement reversed some effects in mice.
A UCSF study indicates that current vitamin B12 guidelines may not protect the aging brain, as lower active B12 levels are linked to cognitive issues and brain damage in older adults.
Scientists have identified the enzyme IDOL as a potential new target for Alzheimer's treatment, finding that its removal from neurons significantly reduced amyloid plaques and improved brain resilience in lab studies.
A study found that extended fasting causes significant biological changes in the human body, with major transformations occurring after about three days without food, affecting organs and protein activity.
A new study reveals that the amino acid arginine can significantly reduce toxic amyloid protein buildup and inflammation in animal models of Alzheimer's disease.
New research shows coffee, both caffeinated and decaffeinated, positively impacts the gut microbiome, mood, and cognitive functions.
Researchers discovered that boosting a protein called Sox9 helps the brain's astrocytes clear Alzheimer's plaques and preserve cognitive function in mice.